Skip Nav DestinationYou do not currently have access to this content.
FDA adds prevention of oropharyngeal cancer to HPV vaccine’s indication
May 1, 2021
from the Food and Drug Administration’s Office of Pediatric Therapeutics and Center for Drug Evaluation and Research, Division of Pediatric and Maternal Health and Center for Biologics and Research
Article type: FDA Update
Don't already have an account? Register